| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.2M | +8.0% |
| SG&A Expense | $21.7M | +5.5% |
| Operating Income | -$75.9M | -7.3% |
| Net Income | -$74.7M | -7.7% |
| EPS (Basic) | -$2.69 | -7.2% |
| EPS (Diluted) | -$2.69 | -7.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.6M | +115.9% |
| Current Assets | $164.0M | -28.0% |
| Total Assets | $184.2M | -24.0% |
| Current Liabilities | $9.1M | +38.1% |
| Long-term Debt | $0 | — |
| Total Liabilities | $16.6M | +84.8% |
| Stockholders' Equity | $167.5M | -28.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.9M | +5.9% |
| Capital Expenditures | $2.1M | -10.3% |
| Investing Cash Flow | $68.0M | +85.7% |
| Financing Cash Flow | $200K | +106.1% |
| Free Cash Flow | -$56.0M | +6.0% |